94 related articles for article (PubMed ID: 6131438)
1. Antiapomorphine and locomotor effects of neuroleptics in rhesus monkeys.
Porsolt RD; Roux S; Jalfre M
Pharmacol Biochem Behav; 1982 Dec; 17(6):1309-12. PubMed ID: 6131438
[TBL] [Abstract][Full Text] [Related]
2. [Comparative study of the pharmacological properties of sultopride sulpiride and other antipsychotic drugs: influence of sultopride, sulpiride and other antipsychotic drugs on spontaneous locomotor activity and changes in locomotor activity induced by apomorphine and clonidine in mice].
Horikomi K; Fujita M
Yakubutsu Seishin Kodo; 1986 Sep; 6(3):339-52. PubMed ID: 2880435
[TBL] [Abstract][Full Text] [Related]
3. The effects of some atypical neuroleptics on apomorphine-induced behaviors as a measure of their relative potencies in blocking presynaptic versus postsynaptic dopamine receptors.
Robertson A; MacDonald C
Pharmacol Biochem Behav; 1986 Jun; 24(6):1639-43. PubMed ID: 2874567
[TBL] [Abstract][Full Text] [Related]
4. Involvement of different dopamine receptors in rat diphasic motility response to apomorphine.
Vaccheri A; Dall'Olio R; Gandolfi O; Montanaro N
Psychopharmacology (Berl); 1986; 89(3):265-8. PubMed ID: 2873607
[TBL] [Abstract][Full Text] [Related]
5. Effects of penfluridol and other drugs on apomorphine-induced stereotyped behavior in monkeys.
Shintomi K; Yamamura M
Eur J Pharmacol; 1975 Apr; 31(2):273-80. PubMed ID: 1171014
[TBL] [Abstract][Full Text] [Related]
6. Neuropharmacological profile of MD 790501, a new benzamide derivative.
Jalfre M; Bucher B; Dorme N; Mocquet G; Porsolt RD
Arch Int Pharmacodyn Ther; 1983 Aug; 264(2):232-56. PubMed ID: 6139097
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of apomorphine-induced hypermotility in rats by chlorpromazine, perphenazine, thioridazine and melperone.
Lassen JB
Acta Pharmacol Toxicol (Copenh); 1977 Mar; 40(3):418-29. PubMed ID: 576565
[TBL] [Abstract][Full Text] [Related]
8. Benzamides and classical neuroleptics: comparison of their actions using 6 apomorphine-induced effects.
Puech AJ; Simon P; Boissier JR
Eur J Pharmacol; 1978 Aug; 50(4):291-300. PubMed ID: 29758
[TBL] [Abstract][Full Text] [Related]
9. Impairment of responses to novelty by apomorphine and its antagonism by neuroleptics in mice.
Misslin R; Ropartz P; Jung L
Psychopharmacology (Berl); 1984; 82(1-2):113-7. PubMed ID: 6141583
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological characterization of the receptors involved in the apomorphine-induced polyphasic modifications of locomotor activity in mice.
Protais P; Bonnet JJ; Costentin J
Psychopharmacology (Berl); 1983; 81(2):126-34. PubMed ID: 6138794
[TBL] [Abstract][Full Text] [Related]
11. Antagonism of hypothermia and behavioral response to apomorphine: a simple, rapid and discriminating test for screening antidepressants and neuroleptics.
Puech AJ; Chermat R; Poncelet M; Doaré L; Simon P
Psychopharmacology (Berl); 1981; 75(1):84-91. PubMed ID: 6117921
[TBL] [Abstract][Full Text] [Related]
12. Behavioral pharmacologic studies in the monkey with DD-3480.
Shibuya T; Nishimori T; Matsuda H; Chen PC
Int J Clin Pharmacol Ther Toxicol; 1982 Jun; 20(6):251-4. PubMed ID: 6125481
[TBL] [Abstract][Full Text] [Related]
13. Injection of apomorphine--a test to predict individual different dopaminergic sensitivity?
Surmann A; Havemann-Reinecke U
J Neural Transm Suppl; 1995; 45():143-55. PubMed ID: 8748620
[TBL] [Abstract][Full Text] [Related]
14. Suitability of amfonelic acid-induced locomotor stimulation in mice as a model for the evaluation of classical and atypical antipsychotics.
Menon MK; Haddox VG
Neuropharmacology; 1984 May; 23(5):555-61. PubMed ID: 6146108
[TBL] [Abstract][Full Text] [Related]
15. Antagonism by haloperidol of locomotor depression induced by small doses of apomorphine.
Strömbom U
J Neural Transm; 1977; 40(3):191-4. PubMed ID: 874471
[TBL] [Abstract][Full Text] [Related]
16. Antipsychotic substances and dopamine in the rat brain; behavioral studies reveal distinct dopamine receptor systems.
Van Ree JM; Elands J; Király I; Wolterink G
Eur J Pharmacol; 1989 Aug; 166(3):441-52. PubMed ID: 2572429
[TBL] [Abstract][Full Text] [Related]
17. Neuroleptic-induced reduction of quipazine-elicited head-twitches in rats: possible involvement of striatal dopaminergic supersensitivity.
Dall'Olio R; Vaccheri A; Gandolfi O; Roncada P; Montanaro N
Pharmacol Biochem Behav; 1988 Dec; 31(4):941-4. PubMed ID: 2908069
[TBL] [Abstract][Full Text] [Related]
18. Is it possible to predict the clinical effects of neuroleptics from animal data? Part V: From haloperidol and pipamperone to risperidone.
Janssen PA; Awouters FH
Arzneimittelforschung; 1994 Mar; 44(3):269-77. PubMed ID: 7514873
[TBL] [Abstract][Full Text] [Related]
19. Relationship between pD2 and pA2 of neuroleptics.
Morgenstern R; Strutz G
Acta Biol Med Ger; 1980; 39(1):133-9. PubMed ID: 6106991
[TBL] [Abstract][Full Text] [Related]
20. Hypokinesia in mice and catalepsy in rats elicited by morphine associated with antidopaminergic agents, including atypical neuroleptics.
Barghon R; Protais P; Colboc O; Costentin J
Neurosci Lett; 1981 Nov; 27(1):69-73. PubMed ID: 6120489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
